Free Trial

Canada Pension Plan Investment Board Grows Position in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

Canada Pension Plan Investment Board lifted its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 33.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 103,100 shares of the business services provider's stock after purchasing an additional 26,100 shares during the quarter. Canada Pension Plan Investment Board owned 0.06% of Genpact worth $4,428,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of the stock. Blue Trust Inc. boosted its holdings in shares of Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider's stock worth $217,000 after purchasing an additional 441 shares in the last quarter. Burney Co. boosted its stake in Genpact by 242.8% in the fourth quarter. Burney Co. now owns 130,798 shares of the business services provider's stock worth $5,618,000 after buying an additional 92,641 shares in the last quarter. KBC Group NV bought a new position in Genpact during the fourth quarter valued at approximately $298,000. JPMorgan Chase & Co. raised its stake in shares of Genpact by 192.8% during the third quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock worth $122,701,000 after acquiring an additional 2,060,595 shares in the last quarter. Finally, State of New Jersey Common Pension Fund D bought a new stake in shares of Genpact in the 4th quarter worth approximately $2,030,000. 96.03% of the stock is currently owned by institutional investors.

Genpact Price Performance

G opened at $47.35 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. The stock has a market capitalization of $8.32 billion, a PE ratio of 16.67, a price-to-earnings-growth ratio of 1.84 and a beta of 1.06. The stock's 50 day moving average price is $50.19 and its 200-day moving average price is $46.19. Genpact Limited has a 52-week low of $30.38 and a 52-week high of $56.76.

Genpact (NYSE:G - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were issued a dividend of $0.17 per share. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.44%. Genpact's dividend payout ratio is 23.94%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on G. Needham & Company LLC increased their target price on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a report on Friday, February 7th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and lifted their price objective for the stock from $44.00 to $55.00 in a report on Tuesday, January 21st. TD Cowen upgraded Genpact from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Mizuho lifted their price target on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Five investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $50.38.

Check Out Our Latest Stock Analysis on G

Insider Transactions at Genpact

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. The trade was a 4.20 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Corporate insiders own 2.80% of the company's stock.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G - Free Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Massive Buybacks: 3 Stocks Insiders Are Buying Up
Nuclear Energy’s Comeback: 7 Stocks to Watch in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines